Baseline BMI is associated with clinical symptom improvements in first-episode schizophrenia: a longitudinal study

Baseline BMI is associated with clinical symptom improvements in first-episode schizophrenia: a longitudinal study

Background: There is sufficient evidence of the high prevalence of obesity in schizophrenia (SZ) compared to the general population. Previous studies have reported that weight gain correlated with the response to antipsychotics in patients with SZ. Nonetheless, the relationship between body mass ind...

Full description

Bibliographic Details
Main Authors: Xiaofang Chen, Yong Fan, Wenchao Ren, Maodi Sun, Xiaoni Guan, Meihong Xiu, Shuyun Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Pharmacology
Subjects:
schizophrenia
weight
improvements
negative symptoms
risperidone
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1264591/full

Similar Items

Similar Items